TEK, TEK receptor tyrosine kinase, 7010

N. diseases: 300; N. variants: 17
Disease: ovarian neoplasm ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm 		0.070 Biomarker disease BEFREE Angiopoietin 1 and 2 regulate angiogenesis and vascular remodelling by interacting with the tyrosine kinase receptor Tie2, and inhibition of angiogenesis has shown promise in the treatment of ovarian cancer. 31076365 2019
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm 		0.070 Biomarker disease BEFREE We studied the efficacy of adenoviral (Ad) gene therapy with soluble VEGFR2 and Tie2 combined with paclitaxel and carboplatin for the treatment of ovarian cancer. 28498260 2017
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm 		0.070 Biomarker disease BEFREE The combined values of Ang1 and Tie2 are predictive biomarkers for improved PFS in bevacizumab-treated patients with ovarian cancer. 24947924 2014
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm 		0.070 Biomarker disease BEFREE In conclusion, combined inhibition of VEGFR-1, VEGFR-3 and Tie2 pathways was safe and provided efficient therapy for ovarian cancer in mice. 20865022 2011
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm 		0.070 Biomarker disease BEFREE Additionally, the hiwi expression was positively correlated with Ang-2 in UCC, BC and OC, and Tie-2 in OC. 20204292 2010
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm 		0.070 Biomarker disease BEFREE Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer. 12138242 2002
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm 		0.070 AlteredExpression disease BEFREE Expression of TP and TIE2 genes in normal ovary with corpus luteum and in ovarian cancer: correlation with ultrasound-derived peak systolic velocity. 10729313 2000